Company Filing History:
Years Active: 1989
Title: F Patrick Carr: Innovator in Leukotriene Antagonists
Introduction
F Patrick Carr is a notable inventor based in Indianapolis, IN (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of 3 patents, focusing primarily on leukotriene antagonists, which play a crucial role in treating various medical conditions.
Latest Patents
Carr's latest patents include innovative formulations of benzene derivatives that act as leukotriene antagonists. These inventions provide methods for using these derivatives to treat conditions characterized by an excessive release of leukotrienes. His work in this area has significant implications for improving patient outcomes in related health issues.
Career Highlights
F Patrick Carr is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and research. His role at the company has allowed him to contribute to groundbreaking advancements in medical treatments.
Collaborations
Throughout his career, Carr has collaborated with esteemed colleagues, including Robert D Dillard and Doris E McCullough. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.
Conclusion
F Patrick Carr's work in developing leukotriene antagonists showcases his dedication to advancing medical science. His contributions continue to impact the field positively, making him a significant figure in pharmaceutical innovation.